Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
EMA announced the reallocation of the medicines for which the MHRA is currently rapporteur or co-rapporteur. Over 370 central- ly authorized products have been transferred to the EU27 Member States ─ plus Iceland and Norway ─ following a methodology developed by EMA’s working groups. Further details are explained in a report.
[/membership]